Tageja, N., Korde, N., Kazandjian, D., Manasanch, E., Bhutani, M., Kwok, M., . . . Landgren, O. (2018). Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma. Bone Marrow Transplant.
Chicago Stili AlıntıTageja, Nishant, et al. "Combination Therapy With Carfilzomib, Lenalidomide and Dexamethasone (KRd) Results in an Unprecedented Purity of the Stem Cell Graft in Newly Diagnosed Patients With Myeloma." Bone Marrow Transplant 2018.
MLA AlıntıTageja, Nishant, et al. "Combination Therapy With Carfilzomib, Lenalidomide and Dexamethasone (KRd) Results in an Unprecedented Purity of the Stem Cell Graft in Newly Diagnosed Patients With Myeloma." Bone Marrow Transplant 2018.